Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Hemorrhagic shock as a complication of anticoagulant therapy following the mitral valve replacement
1University Hospital Zagreb, Department of anesthesiology, reanimatology and intensive care
2,University Hospital for infective diseases «Fran Mihaljević»
*Corresponding Author(s): TAJANA ZAH E-mail: tajanazah@gmail.com
This report describes a case of the hemorrhagic shock in a patient on the anticoagulant therapy supplementing implanted mechanical prosthetic heart valve replacing the mitral valve. The association between hemorrhagic shock, mechanical prosthetic heart valve and anticoagulant therapy is briefly discussed.
hemorrhagic shock, mechanical prosthetic heart valve, anticoagulant therapy
TAJANA ZAH,VIŠNJA IVANČAN,DINKO TONKOVIĆ,ŽELJKO KRZNARIĆ,IGOR KLINAR,VIŠNJA MAJERIĆ KOGLER . Hemorrhagic shock as a complication of anticoagulant therapy following the mitral valve replacement. Signa Vitae. 2007. 2(2);23-24.
1. The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126;287-310.
2. Levine NM, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment Chest 1995;276s-290s.
3. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1995;108(4Suppl):231S-246.
4. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and predictive factors known at the start of outpatient therapy. Am J Med 1989;87:144-152.
5. Clexane® (enoxaparin) product information. Avensis Pharmaceuticals
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 1.3 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.
Top